New data from CFIB, EDC and Statistics Canada shows small exporters and importers are running out of runway as tariffs bite
The Canada-U.S. trade war is pushing Canadian small businesses toward a breaking point, with multiple data releases painting a consistent and concerning picture of an export economy under sustained pressure and a growing divide between large businesses that can adapt and smaller firms that cannot.
Statistics Canada reported on September 3, 2026, that Canada's merchandise exports fell 2.3% in July, snapping five consecutive months of gains.
Exports to the United States dropped 6.6%, the sharpest monthly decline since April 2025, while Canada's trade surplus with the U.S. narrowed from $10.3 billion in June to $5.9 billion in July, the lowest level since February 2026.
The broader goods trade surplus with the world shrank from $4.2 billion in June to $769 million in July. The data, drawn from Statistics Canada's monthly merchandise trade release, underscores just how quickly conditions are shifting for Canadian exporters.
The one bright spot in the Statistics Canada figures tells a different story: exports to countries other than the United States rose 7.4% in July to reach a record high of $25.6 billion; a third consecutive monthly increase.
Canada's share of exports destined for non-U.S. markets climbed to 33.7% in July, the highest in recent months, driven by stronger shipments to the Netherlands, China and Germany.
Small businesses on the front line
Against this backdrop, a survey released the same day by the Canadian Federation of Independent Business (CFIB), which represents 103,000 small and medium-sized businesses across Canada, confirmed that the tariff burden is falling hardest on the smallest operators.
Some 46% of small exporters and 49% of small importers have products directly caught in the crossfire of U.S. tariffs and Canadian counter-tariffs. One in five small exporters (18%) say they would cease to be financially viable if the trade war continues for three months or more. Among small importers, 11% said the same.
"We cannot allow small business owners to become cannon fodder in the trade war," said Dan Kelly, president of CFIB. "If we're going to retaliate, then we need to make sure government supports protect the small businesses being put on the front lines of the trade war."
Manufacturing, wholesale, retail and construction are among the most affected sectors; industries that form a significant portion of the client base for financial advisors and wealth managers working with business-owner clients across Canada. As Wealth Professional has previously reported on the strain facing small businesses throughout the trade war, the situation continues to deteriorate.
CFIB vice-president of national affairs Jasmin Guénette warned that businesses face compounding pressures: "We're talking about people who are being asked to put their entire livelihoods on the line so that Canada can push back. The government needs to move with urgency and get relief measures in place."
The organization is proposing a dedicated Small Business Tariff Relief program offering initial support of up to $70,000 CAD for eligible exporters and importers.
CFIB is also calling for the small business corporate tax rate to be cut from 9% to 6%, retroactive to January 1, 2026, and for the Small Business Deduction threshold to rise from $500,000 to $700,000, measures that, if enacted, would meaningfully improve after-tax cash flows for owner-operator clients.
Larger exporters adapt through diversification
Export Development Canada (EDC) released its mid-year Trade Confidence Index (TCI) on the same date, based on 1,015 exporters surveyed between June 8 and July 27, 2026.
The index edged up to 71.7 from 69.7 at year-end 2025, a modest improvement that EDC Chief Economist Stuart Bergman attributed to a structural shift in how businesses are approaching uncertainty.
"What we're seeing is a shift from a reactive mindset to one of greater resilience and resolve," said Bergman. "Businesses are bolstering their domestic operations, investing in productivity, and strengthening their supply chains — all of which enhances their ability to break into new export markets."
Seventy-two per cent of exporters surveyed by EDC plan to enter new markets within two years, up from 65% five months prior.
Europe (31%) and the Asia-Pacific region (20%) are the most-cited destinations, a trajectory that aligns directly with the Statistics Canada data showing record non-U.S. export volumes in July. Exporters that combine domestic sales, imports and foreign investment recorded a TCI of 72.7, ahead of those focused exclusively on the U.S. market at 69.5.
It is worth noting that the EDC survey was conducted before the U.S. imposed 50% tariffs on a range of Canadian goods on August 22, 2026, under Section 338 of the U.S. Tariff Act of 1930.
EDC acknowledged that its findings therefore do not capture the most recent escalation, a critical caveat for advisors using this data in client conversations. Nearly one-third of exporters (32%) already reported weaker U.S. orders over the prior six months, and 42% expect sales to remain at lower levels.
The broader economic outlook for Canada in 2026 remains subdued, with trade uncertainty continuing to weigh on business valuations, consumer spending and investment planning across the country.
Pharmaceutical sector adds another risk layer
A third data point released September 3, 2026, adds a sector-specific dimension for advisors with client exposure to life sciences.
Innovative Medicines Canada (IMC), which represents more than 40 member pharmaceutical companies in Ottawa, welcomed a Deloitte Canada report confirming the innovative pharmaceutical industry contributes $25 billion to Canada's economy, supports approximately 150,000 high-value jobs, and invests $3.5 billion annually in research and development, outpacing both the automotive and aerospace manufacturing industries in R&D spending.
Deloitte's analysis found that every dollar invested in the sector generates nearly $3 in economic value through employment, labour income and government revenue.
IMC cautioned, however, that global drug pricing shifts, specifically the introduction of most-favoured nation (MFN) pricing in the U.S., now threaten both that economic footprint and Canadian patient access to life-saving medicines.
"This data confirms what we have long known: that the innovative pharmaceutical industry is not just about better health outcomes; it is a foundational part of Canada's economy," said Dr. Bettina Hamelin, President and CEO of Innovative Medicines Canada. "We must recognize the value this industry brings to Canada and ensure the policy environment supports its contributions."
For wealth professionals assessing sector concentration or advising clients in life sciences, the IMC warning represents a material risk factor: one that sits alongside the broader trade headwinds now flowing through Canada's export data.
What this means for advisors and their clients
Canada's aggregate trade position is shifting with non-U.S. export volumes rising and business confidence among larger exporters holding. But smaller firms, which make up the majority of Canada's export base, are absorbing costs they cannot sustain indefinitely.
Business-owner clients in export-dependent sectors need updated cash flow projections, revised succession and estate planning assumptions, and a clear understanding of which proposed federal relief measures could improve their position.
Advisors managing portfolios with Canadian small-cap or sector-specific equity exposure should factor in both the pharmaceutical policy risk and the persistent drag on small business earnings that the CFIB data confirms.
The Canada-U.S. trade conflict is no longer a planning assumption, butwealth an active variable reshaping the financial outlook of thousands of Canadian businesses and, by extension, their owners' personal wealth trajectories.
